Advertisement

Topics

Syndax in-licenses portfolio of blood cancer candidates

08:10 EDT 19 Oct 2017 | thePharmaLetter

Syndax Pharmaceuticals has entered into an exclusive worldwide license agreement with Vitae Pharmaceuticals,…

Original Article: Syndax in-licenses portfolio of blood cancer candidates

NEXT ARTICLE

More From BioPortfolio on "Syndax in-licenses portfolio of blood cancer candidates"

Quick Search
Advertisement
 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...